Skip to contentM
Myriad Genetics Inc
M
MYGNMyriad Genetics Inc Q3 2018 · 10-Q
Revenue$202.30M$202.30Mno prior Q3 2017 on file Net Income-$700.00K-$700.00Kno prior Q3 2017 on file EPS Diluted-$0.01-$0.01no prior Q3 2017 on file Operating Income$1,200,000— Operating Cash Flow
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Myriad Genetics Inc · CIK 899923 · Engraved from SEC EDGAR
Free Cash Flowderived$6,500,000— Margins · derivedOperating margin0.6%
Net margin-0.3%
ended Sep 30, 2018 · filed Nov 7, 2018 · 38 d after period end